- 2014
-
Press releases - 09.04.2014
Caffeine and Alzheimer’s disease : a link with tau protein
Researchers at Inserm and University of Lille 2/University of Lille Nord de France directed by David Blum, Inserm Research Fellow, have provided experimental evidence of the beneficial effects of caffeine in an animal model of Alzheimer’s disease. This work, carried out on mice and published in Neurobiology of Aging, supports the idea that caffeine has a protective effect in some brain pathologies.
-
Press releases - 08.04.2014
A natural protein, Elafin against gluten intolerance?
Scientists from INRA and INSERM (France) have shown that Elafin, a human protein, plays a key role against the inflammatory reaction typical of celiac disease (gluten intolerance).
-
News in brief - 07.04.2014
How do our cells grow?
Some cells in our bodies need to increase their surface area significantly in order to perform their functions. This is particularly true of neurons, whose cell membrane surface area increases by 20% every day during development. When neurons reach maturity, their membrane surface area is 250,000 µm², totalling 25000 m² when all the neurons in […]
-
Press releases - 07.04.2014
Friedreich’s ataxia – an effective gene therapy in an animal model
The team led by Hélène Puccio, director of research for Inserm at the Institute of Genetics and Molecular and Cellular Biology (IGBMC) (Inserm / CNRS / University of Strasbourg) in close collaboration with Patrick Aubourg’s team (Inserm and Professor of Neuropaediatrics at Bicêtre Hospital) has demonstrated, in the mice, the efficacy of gene therapy for […]
-
What's on? - 03.04.2014
Ebola virus : Inserm’s P4 laboratory mobilised
In the last 24 hours, the World Health Organisation (WHO), in a communiqué published by the UN, has reported that it has recorded 5 new cases of Ebola fever in Guinea. Since January the total number of suspected and confirmed cases of Ebola fever in the present outbreak in Guinea is 127, with 83 deaths, […]
-
Press releases - 03.04.2014
Europeans and biomedical research
The French National Institute of Health and Medical Research (Inserm) is currently the leading biomedical research organisation in Europe, and plays a key role in developing European research. To mark its 50th anniversary, Inserm wanted to assess the perceptions of Europeans regarding biomedical research.
-
Press releases - 31.03.2014
Yes, you can make your children eat vegetables!
Researchers have made a step forward in the understanding of how eating behaviours and preferences form in early life.
-
What's on? - 28.03.2014
Putting the clocks forward : what are the impacts on health?
During this last weekend in March, we will be switching to summer time. On the night between Saturday and Sunday, we must put our watches and clocks forward by one hour. What do we currently know about the impact of changing the time on our health? Does it upset our biological clock? Find out more […]
-
Press releases - 27.03.2014
Breast milk and diet up to 2 years old: a means of preventing the risk of child obesity
From analysis of data from the ELANCE cohort, Marie Françoise Rolland-Cachera, former researcher at Inserm and her co-workers in the Nutritional Epidemiology Research Team (EREN)[1] have shown that breast-feeding has a protective effect on the risk of obesity at 20 years of age.
-
Press releases - 26.03.2014
Ribavirin – an effective and safe treatment for hepatitis E
Vincent Mallet, Stanislas Pol and their team at the Institut Cochin (Paris Descartes University, Assistance Publique – Hôpitaux de Paris, CNRS, Inserm) and French hospital-based teams* have proved the efficacy of a treatment for patients suffering from chronic hepatitis E virus infection.